Frequency of periprocedural myocardial injury and infarction stratified by cardiac troponin I and cardiac troponin T

IF 1.6 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Cardiovascular Revascularization Medicine Pub Date : 2025-01-01 DOI:10.1016/j.carrev.2024.05.022
Pruthvi C. Revaiah , Tsung-Ying Tsai , Bo Wang , Mick Renkens , Shigetaka Kageyama , Adrian Wlodarczak , Julien Lemoine , Helge Mollmann , Manel Sabate , Faisal Sharif , Azfar Zaman , Joanna Wykrzykowska , Edouard Benit , He Xing Qiang , Kotaro Miyashita , Akihiro Tobe , Takashi Muramatsu , Kengo Tanabe , Yukio Ozaki , Scot Garg , Patrick W. Serruys
{"title":"Frequency of periprocedural myocardial injury and infarction stratified by cardiac troponin I and cardiac troponin T","authors":"Pruthvi C. Revaiah ,&nbsp;Tsung-Ying Tsai ,&nbsp;Bo Wang ,&nbsp;Mick Renkens ,&nbsp;Shigetaka Kageyama ,&nbsp;Adrian Wlodarczak ,&nbsp;Julien Lemoine ,&nbsp;Helge Mollmann ,&nbsp;Manel Sabate ,&nbsp;Faisal Sharif ,&nbsp;Azfar Zaman ,&nbsp;Joanna Wykrzykowska ,&nbsp;Edouard Benit ,&nbsp;He Xing Qiang ,&nbsp;Kotaro Miyashita ,&nbsp;Akihiro Tobe ,&nbsp;Takashi Muramatsu ,&nbsp;Kengo Tanabe ,&nbsp;Yukio Ozaki ,&nbsp;Scot Garg ,&nbsp;Patrick W. Serruys","doi":"10.1016/j.carrev.2024.05.022","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div><span>There are different definitions of periprocedural myocardial infarction (PPMI) both in terms of thresholds for cardiac biomarkers and the ancillary criteria for myocardial ischemia. Cardiac </span>Troponin I<span> (cTnI) and cardiac Troponin T (cTnT) are used interchangeably to diagnose PPMI.</span></div></div><div><h3>Objectives</h3><div>This study evaluated the frequency of periprocedural myocardial injury<span><span> and infarction as defined by the Society of Cardiovascular Angiography &amp; Interventions (SCAI), the Academic Research Consortium-2 (ARC-2), and the 4th Universal definition of MI (4UDMI) stratified using cTnT versus cTnI, among patients with chronic coronary syndrome (CCS) and </span>unstable angina.</span></div></div><div><h3>Results</h3><div>Among 830 patients, PPMI rates according to the SCAI, ARC2 and 4UDMI criteria were 4.34 %, 2.05 %, and 4.94 % respectively, with higher rates seen for all definitions when using cTnI versus cTnT (SCAI: 9.84 % vs. 1.91 %, <em>p</em> &lt; 0.001; ARC 2: 3.15 % vs. 1.56 %, <em>p</em> = 0.136; and 4UDMI 5.91 % vs. 4.51 %, <em>p</em><span> = 0.391). Minor and major periprocedural myocardial injury was respectively observed in 58.31 % and 27.10 % of patients, with rates of both significantly higher when using cTnI versus cTnT (Minor: 69.29 % vs. 53.47 %, p &lt; 0.001, Major: 49.21 % vs. 17.36 %, p &lt; 0.001).</span></div></div><div><h3>Conclusions</h3><div>Among patients with CCS and unstable angina<span>, PPMIs defined by SCAI occurred more frequently when using cTnI as opposed to cTnT, whereas the type of troponin had no impact on the incidence of PPMIs according to the ARC-2 and 4UDMI.</span></div></div>","PeriodicalId":47657,"journal":{"name":"Cardiovascular Revascularization Medicine","volume":"70 ","pages":"Pages 12-19"},"PeriodicalIF":1.6000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular Revascularization Medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1553838924004913","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background

There are different definitions of periprocedural myocardial infarction (PPMI) both in terms of thresholds for cardiac biomarkers and the ancillary criteria for myocardial ischemia. Cardiac Troponin I (cTnI) and cardiac Troponin T (cTnT) are used interchangeably to diagnose PPMI.

Objectives

This study evaluated the frequency of periprocedural myocardial injury and infarction as defined by the Society of Cardiovascular Angiography & Interventions (SCAI), the Academic Research Consortium-2 (ARC-2), and the 4th Universal definition of MI (4UDMI) stratified using cTnT versus cTnI, among patients with chronic coronary syndrome (CCS) and unstable angina.

Results

Among 830 patients, PPMI rates according to the SCAI, ARC2 and 4UDMI criteria were 4.34 %, 2.05 %, and 4.94 % respectively, with higher rates seen for all definitions when using cTnI versus cTnT (SCAI: 9.84 % vs. 1.91 %, p < 0.001; ARC 2: 3.15 % vs. 1.56 %, p = 0.136; and 4UDMI 5.91 % vs. 4.51 %, p = 0.391). Minor and major periprocedural myocardial injury was respectively observed in 58.31 % and 27.10 % of patients, with rates of both significantly higher when using cTnI versus cTnT (Minor: 69.29 % vs. 53.47 %, p < 0.001, Major: 49.21 % vs. 17.36 %, p < 0.001).

Conclusions

Among patients with CCS and unstable angina, PPMIs defined by SCAI occurred more frequently when using cTnI as opposed to cTnT, whereas the type of troponin had no impact on the incidence of PPMIs according to the ARC-2 and 4UDMI.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
按心肌肌钙蛋白 I 和心肌肌钙蛋白 T 分层的围手术期心肌损伤和心肌梗死的发生率。
背景:在心脏生物标志物的阈值和心肌缺血的辅助标准方面,围术期心肌梗死(PPMI)有不同的定义。心肌肌钙蛋白 I(cTnI)和心肌肌钙蛋白 T(cTnT)可交替用于诊断 PPMI:本研究评估了心血管血管造影和介入学会(SCAI)、学术研究联盟-2(ARC-2)和第四代心肌梗死通用定义(4UDMI)所定义的慢性冠状动脉综合征(CCS)和不稳定型心绞痛患者中使用 cTnT 与 cTnI 进行分层的围术期心肌损伤和心肌梗死的频率:在 830 名患者中,根据 SCAI、ARC2 和 4UDMI 标准得出的 PPMI 比率分别为 4.34 %、2.05 % 和 4.94 %,使用 cTnI 与 cTnT 相比,所有定义的 PPMI 比率都更高(SCAI:9.84 % 对 1.91 %,P 结论:在慢性冠状动脉综合征(CCS)和不稳定型心绞痛患者中,使用 cTnT 与 cTnI 分层的 PPMI 比率分别为 4.34 %、2.05 % 和 4.94 %:在CCS和不稳定型心绞痛患者中,使用cTnI和cTnT时,SCAI定义的PPMI发生率更高,而根据ARC-2和4UDMI,肌钙蛋白的类型对PPMI的发生率没有影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Cardiovascular Revascularization Medicine
Cardiovascular Revascularization Medicine CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
3.30
自引率
5.90%
发文量
687
审稿时长
36 days
期刊介绍: Cardiovascular Revascularization Medicine (CRM) is an international and multidisciplinary journal that publishes original laboratory and clinical investigations related to revascularization therapies in cardiovascular medicine. Cardiovascular Revascularization Medicine publishes articles related to preclinical work and molecular interventions, including angiogenesis, cell therapy, pharmacological interventions, restenosis management, and prevention, including experiments conducted in human subjects, in laboratory animals, and in vitro. Specific areas of interest include percutaneous angioplasty in coronary and peripheral arteries, intervention in structural heart disease, cardiovascular surgery, etc.
期刊最新文献
Safety and efficacy of the unilateral, suture-based, dry-closure technique in percutaneous trans-axillary aortic valve implantation. Outcomes of aortic stenosis in patients with cardiac amyloidosis: A systematic review and meta-analysis. The role of Pulmonary Artery Pulsatility Index to assess the outcomes following catheter directed therapy in patients with intermediate-to-high and high-risk pulmonary embolism. Sex-related differences in hospital outcomes after balloon aortic valvuloplasty. Clinical safety and performance of the third-generation Fantom Encore sirolimus-eluting bioresorbable scaffold: Insights from a single-center study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1